ARCHIVES

Benefit Seen In Novel Drug That Treats Gleevec Resistance

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: St. Jude To Stay In Memphis; Katterhagens Move To Illinois; ACCC, Nixon In DC Next Week

March 28, 1986

In Brief: Panel Appointments On President’s Desk; Breast Cancer Treatment Workshop Planned

September 14, 1979

Program Announcement listed.

July 25, 2003

Targeting Men At High Risk Finds More Head & Neck Cancer

September 24, 2010

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

November 19, 2010

Some NCI Responses To CCOP Letters Of Intent Missing; NCAB Debates Pediatric Issues

October 8, 1982